Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Open Label, Randomized Trial of TDF/FTC+Raltegravir Vs. TDF/FTC+Efavirenz in HIV-1-Infected Women: Differential Effects on Viral Suppression/Reservoir, & Immune Parameters in Different Compartments, Including Gut & Genital Tract
Status: Archived
University of Chicago
270
mi
from 43215
Chicago, IL
Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Open Label, Randomized Trial of TDF/FTC+Raltegravir Vs. TDF/FTC+Efavirenz in HIV-1-Infected Women: Differential Effects on Viral Suppression/Reservoir, & Immune Parameters in Different Compartments, Including Gut & Genital Tract
Status: Archived
Updated: 1/1/1970
University of Chicago
270
mi
from 43215
Chicago, IL
Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Open Label, Randomized Trial of TDF/FTC+Raltegravir Vs. TDF/FTC+Efavirenz in HIV-1-Infected Women: Differential Effects on Viral Suppression/Reservoir, & Immune Parameters in Different Compartments, Including Gut & Genital Tract
Status: Archived
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Open Label, Randomized Trial of TDF/FTC+Raltegravir Vs. TDF/FTC+Efavirenz in HIV-1-Infected Women: Differential Effects on Viral Suppression/Reservoir, & Immune Parameters in Different Compartments, Including Gut & Genital Tract
Status: Archived
Updated: 1/1/1970
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Open Label, Randomized Trial of TDF/FTC+Raltegravir Vs. TDF/FTC+Efavirenz in HIV-1-Infected Women: Differential Effects on Viral Suppression/Reservoir, & Immune Parameters in Different Compartments, Including Gut & Genital Tract
Status: Archived
University of Illinois College of Medicine
276
mi
from 43215
Chicago, IL
Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Open Label, Randomized Trial of TDF/FTC+Raltegravir Vs. TDF/FTC+Efavirenz in HIV-1-Infected Women: Differential Effects on Viral Suppression/Reservoir, & Immune Parameters in Different Compartments, Including Gut & Genital Tract
Status: Archived
Updated: 1/1/1970
University of Illinois College of Medicine
276
mi
from 43215
Chicago, IL
Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Open Label, Randomized Trial of TDF/FTC+Raltegravir Vs. TDF/FTC+Efavirenz in HIV-1-Infected Women: Differential Effects on Viral Suppression/Reservoir, & Immune Parameters in Different Compartments, Including Gut & Genital Tract
Status: Archived
The Ruth M. Rothstein CORE Center (of Cook County)
276
mi
from 43215
Chicago, IL
Trial of TDF/FTC + Raltegravir Versus TDF/FTC + Efavirenz in HIV-1-Infected Women
Open Label, Randomized Trial of TDF/FTC+Raltegravir Vs. TDF/FTC+Efavirenz in HIV-1-Infected Women: Differential Effects on Viral Suppression/Reservoir, & Immune Parameters in Different Compartments, Including Gut & Genital Tract
Status: Archived
Updated: 1/1/1970
The Ruth M. Rothstein CORE Center (of Cook County)
276
mi
from 43215
Chicago, IL
Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
Pilot Study of the Effect of Maraviroc Intensification on Peripheral Blood Monocyte HIV DNA Levels When Given to HIV-Infected Subjects Stable on Highly Active Antiretroviral Therapy With Undetectable Plasma HIV RNA
Status: Archived
Hawaii Center for AIDS
4499
mi
from 43215
Honolulu, HI
Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
Pilot Study of the Effect of Maraviroc Intensification on Peripheral Blood Monocyte HIV DNA Levels When Given to HIV-Infected Subjects Stable on Highly Active Antiretroviral Therapy With Undetectable Plasma HIV RNA
Status: Archived
Updated: 1/1/1970
Hawaii Center for AIDS
4499
mi
from 43215
Honolulu, HI
Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
CCR5 Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Status: Archived
Center for AIDS Research. Case Western Reserve University
129
mi
from 43215
Cleveland, OH
Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
CCR5 Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Status: Archived
Updated: 1/1/1970
Center for AIDS Research. Case Western Reserve University
129
mi
from 43215
Cleveland, OH
Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
CCR5 Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Status: Archived
HIV-1 Immunopathogenesis Laboratory. The Wistar Institute
414
mi
from 43215
Philadelphia, PA
Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
CCR5 Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Status: Archived
Updated: 1/1/1970
HIV-1 Immunopathogenesis Laboratory. The Wistar Institute
414
mi
from 43215
Philadelphia, PA
Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
CCR5 Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Status: Archived
Hospital of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
CCR5 Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
Status: Archived
Updated: 1/1/1970
Hospital of the University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Miller Children's Hospital Long Beach
1975
mi
from 43215
Long Beach, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Miller Children's Hospital Long Beach
1975
mi
from 43215
Long Beach, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
University of Southern California Women's and Children's Hospital
1970
mi
from 43215
Los Angeles, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
University of Southern California Women's and Children's Hospital
1970
mi
from 43215
Los Angeles, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
David Geffen School of Medicine, UCLA
1982
mi
from 43215
Los Angeles, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
David Geffen School of Medicine, UCLA
1982
mi
from 43215
Los Angeles, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
UC San Diego Medical Center
1951
mi
from 43215
San Diego, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
UC San Diego Medical Center
1951
mi
from 43215
San Diego, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
San Francisco General Hospital
2107
mi
from 43215
San Francisco, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
San Francisco General Hospital
2107
mi
from 43215
San Francisco, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
University of California at San Francisco (UCSF)
2109
mi
from 43215
San Francisco, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
University of California at San Francisco (UCSF)
2109
mi
from 43215
San Francisco, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Unversity of California, San Francisco
2108
mi
from 43215
San Francisco, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Unversity of California, San Francisco
2108
mi
from 43215
San Francisco, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Harbor-UCLA Med Ctr
1982
mi
from 43215
Torrance, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Harbor-UCLA Med Ctr
1982
mi
from 43215
Torrance, CA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
University of Colorado, Boulder
1179
mi
from 43215
Boulder, CO
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
University of Colorado, Boulder
1179
mi
from 43215
Boulder, CO
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Howard University Hospital
328
mi
from 43215
Washington,
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Howard University Hospital
328
mi
from 43215
Washington,
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Children's Nutrition Research Center, Baylor College of Medicine
995
mi
from 43215
Houston, TX
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Children's Nutrition Research Center, Baylor College of Medicine
995
mi
from 43215
Houston, TX
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Washington Hospital Center
328
mi
from 43215
Washington,
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Washington Hospital Center
328
mi
from 43215
Washington,
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Children's Doctor
996
mi
from 43215
Houston, TX
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Children's Doctor
996
mi
from 43215
Houston, TX
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
University of Florida Gainesville
714
mi
from 43215
Gainesville, FL
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
University of Florida Gainesville
714
mi
from 43215
Gainesville, FL
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
University of Miami Hospital
993
mi
from 43215
Miami, FL
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
University of Miami Hospital
993
mi
from 43215
Miami, FL
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
University of South Flordia
831
mi
from 43215
Tampa, FL
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
University of South Flordia
831
mi
from 43215
Tampa, FL
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Children`s Hospital of Philadelphia : University of Philadelphia
414
mi
from 43215
Philadelphia, PA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Children`s Hospital of Philadelphia : University of Philadelphia
414
mi
from 43215
Philadelphia, PA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Mount Sinai Hospital Medical Center
275
mi
from 43215
Chicago, IL
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital Medical Center
275
mi
from 43215
Chicago, IL
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Tulane University Medical Center
797
mi
from 43215
New Orleans, LA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Tulane University Medical Center
797
mi
from 43215
New Orleans, LA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Johns Hopkins Hosp
346
mi
from 43215
Baltimore, MD
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Johns Hopkins Hosp
346
mi
from 43215
Baltimore, MD
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
University of Maryland, Baltimore
343
mi
from 43215
Baltimore, MD
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
University of Maryland, Baltimore
343
mi
from 43215
Baltimore, MD
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Boston Med Center
643
mi
from 43215
Boston, MA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Boston Med Center
643
mi
from 43215
Boston, MA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Brigham & Women's Hospital Women's Health Center
637
mi
from 43215
Chestnut Hill, MA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
637
mi
from 43215
Chestnut Hill, MA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Children's Medical Center of Dallas
911
mi
from 43215
Dallas, TX
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Children's Medical Center of Dallas
911
mi
from 43215
Dallas, TX
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Western New England Maternal Pediatric Adolescent
604
mi
from 43215
Worcester, MA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Western New England Maternal Pediatric Adolescent
604
mi
from 43215
Worcester, MA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
New Jersey Medical School Adult Clinical Research Center
468
mi
from 43215
Newark, NJ
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
New Jersey Medical School Adult Clinical Research Center
468
mi
from 43215
Newark, NJ
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Bronx Municipal Hospital Center
486
mi
from 43215
Bronx, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Bronx Municipal Hospital Center
486
mi
from 43215
Bronx, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Columbia Presbyterian Med Ctr
481
mi
from 43215
New York, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
481
mi
from 43215
New York, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
New York University
478
mi
from 43215
New York, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
New York University
478
mi
from 43215
New York, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Metropolitan Hosp. NICHD CRS
480
mi
from 43215
New York, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Metropolitan Hosp. NICHD CRS
480
mi
from 43215
New York, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Bronx Lebanon Hospital Center
483
mi
from 43215
Bronx, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Bronx Lebanon Hospital Center
483
mi
from 43215
Bronx, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
State Univ of New York at Stony Brook
524
mi
from 43215
Stony Brook, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
State Univ of New York at Stony Brook
524
mi
from 43215
Stony Brook, NY
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Saint Peter's University Hospital
453
mi
from 43215
New Brunswick, NJ
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Saint Peter's University Hospital
453
mi
from 43215
New Brunswick, NJ
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Regional Med. Ctr. at Memphis
508
mi
from 43215
Memphis, TN
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Regional Med. Ctr. at Memphis
508
mi
from 43215
Memphis, TN
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
St. Jude Childrens Research Hosp, Memphis
507
mi
from 43215
Memphis, TN
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
St. Jude Childrens Research Hosp, Memphis
507
mi
from 43215
Memphis, TN
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Texas Children's Hospital - Feigin Center
995
mi
from 43215
Houston, TX
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Texas Children's Hospital - Feigin Center
995
mi
from 43215
Houston, TX
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Children's Hospital - Boston
640
mi
from 43215
Boston, MA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
Children's Hospital - Boston
640
mi
from 43215
Boston, MA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
University of Washington
1982
mi
from 43215
Seattle, WA
Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women
A Phase II Study to Assess the Safety and Immunogenicity of an Inactivated Monovalent Influenza A (H1N1) Vaccine in HIV-1 Infected Pregnant Women
Status: Archived
Updated: 1/1/1970
University of Washington
1982
mi
from 43215
Seattle, WA
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
Maraviroc Plus Darunavir/Ritonavir Study for Treatment-Naïve Patients Infected With R5-tropic HIV-1 Based on Enhanced Sensitivity Trofile
Status: Archived
Quest Clinical Research
2108
mi
from 43215
San Francisco, CA
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
Maraviroc Plus Darunavir/Ritonavir Study for Treatment-Naïve Patients Infected With R5-tropic HIV-1 Based on Enhanced Sensitivity Trofile
Status: Archived
Updated: 1/1/1970
Quest Clinical Research
2108
mi
from 43215
San Francisco, CA
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
Maraviroc Plus Darunavir/Ritonavir Study for Treatment-Naïve Patients Infected With R5-tropic HIV-1 Based on Enhanced Sensitivity Trofile
Status: Archived
University of Miami Hospital
993
mi
from 43215
Miami, FL
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
Maraviroc Plus Darunavir/Ritonavir Study for Treatment-Naïve Patients Infected With R5-tropic HIV-1 Based on Enhanced Sensitivity Trofile
Status: Archived
Updated: 1/1/1970
University of Miami Hospital
993
mi
from 43215
Miami, FL